Member Info for magmanus_49

S/H with board decide price! not rice. well rice with cheese soon though!

its called due-diligence and closing price before intent is taken in account always.

Presentation was in line and great as expected. They provided the key reasons- points listed below - they need s/h approval and only they will set the price.

shocking if you panic sold or don't have clue about the significant of their pipeline and values - Present NAV and future NAV values.

Anyway if you sold / shorted on panic Or not in then move on :) posting here makes you look stupid otherwise. :)

S/H all decide with Board - closing rice on Monday 9th Feb was about 175p before intent announced,

Its not a placing its a rights issue where s/h comes first.

Anyway enough said. Sellers are out low and buyers are getting in since Tuesday that's all I know and need to know.

JR - that's our understabding - common sense really

There some bashers who sold on margin that are getting very exciting until it is handed to them from the other side. Mainly the same culprits.

All the rights issues I have seen that have been pre-announced always are much higher there is all lot of due-diligence that goes into these things - price/ close prior to intent announcement etc otherwise we would all be rich - we get intent, sell and buy when we are ready - millionaires lol

I will tell a story here soon enough.

Tomorrow will be fun, keep dry powder handy as always (said on Tuesday and say it again). The rest is history.

No troll/basher in sight now - amazing! They get paid by the post and their time is up.

No troll insights - just its down a penny- oh no. Sell done buy, where is the CEO, oh blood bath, all the same BS. No insights what so ever.

up buy / down accumulate and more important is too hold - its all low here under Monday's close of 175p

ST well done.

No can tell what the PS will do. If its oversold based on fundamentals and technical then its oversold.

Buy when all are fearful and manipulation is ripe in the vacuum.

Should stabilise here on as every seller had waiting buyer since Tuesday open.

have a nice evening, onwards and upwards soon for fellow ss/holder - buyers and accumulators.

Some said no point buying now? duh - I say now point selling now.

Its under the floor

Floor was open on Tuesday 120, its been underground for while here now

Bottom fishing comes to mind

Anyway if you bought consider yourself lucky - you bought a major asset here on the cheap.

As said a lot stock has been soaked up here, and that buyer wont be selling any time soon

Sure bears have been welcomed along with loss sellers - is their chose - they must feel good so far -I am sure.

Stay strong and stay put if you holding and buying back - vacuum provides massive opps.

I hardly buy / trade on AIM - mostly on USA markets and this is an exceptional opp given the past results/ data and global reach of the drug FARN is working hard to through the FDA .

At this point, the stock is down roughly 70% from recent levels, despite no fundamental impairment to the lead asset. That’s a significant re-pricing driven largely by sentiment rather than clinical failure.

For those who accumulated below ~120p, the risk/reward from here looks materially improved. In the short term, a relief rally is possible as uncertainty clears. Longer term, value will hinge on execution and eventual approval — but if milestones are delivered, the upside from current levels could be substantial.

It’s also worth noting that the broader market was volatile today, which likely amplified hesitation and liquidity swings. Some holders may simply have rotated capital elsewhere.

From here, the key variables are:

S/H and Board agree on rights pricing - hopefully 175p minus 30% o fair value basis

Take-up levels

Continued clinical progress

The emotional and short phase of the move appears to have largely played out - more buys than sells — now it becomes about fundamentals and execution.

Any one buying yesterday and today off panic sellers wont be selling soon - they know what they have bought low on panic and purely troll induced.

Also noting - company iterated:

A rights issue helps preserve ownership upside early in the registrational pathway and could strengthen Faron’s negotiating position for a future partnership.

The trial design has been aligned with the FDA and could be an important value inflection point when results start coming out.

A rights issue to existing shareholders first to participate in proportion to their current holdings.

The funding is focused on Phase II portion of the FDA-agreed Phase II/III registrational trial in frontline high-risk myelodysplastic syndrome (HR-MDS).

The offer will be structured with pre-emptive rights for existing shareholders.

Explain ED that the rights issue is a necessary and ideal step to fund development (of advanced treatment to approval) rather than a reflection of lack of progress.

More updates to come. Strong b/hold unless you're are a troll, der-ampers or short - then sell for you.

Summary of the Webcast:

Faron’s rights issue is strategically targeted at funding the next big clinical milestone — the Phase II/III portion of a registrational trial agreed with the FDA.

Structuring it as a rights issue protects existing shareholders by allowing them to participate pro rata.

The company is aligning its development plan with recent regulatory guidance, which could shorten timelines and enhance commercial prospects.

These points were reinforced in the webcast discussion between management and analysts, and are consistent with recent press releases on the offering and clinical strategy.

- An Extraordinary General Meeting (EGM) is scheduled for 2 March 2026 to seek shareholder approval for the rights issue.

- Subscription terms and pricing will be determined by the board after approval AND be based on last closing price before the intent was shared with shareholders and investors.

Overall very positive considering they are also looking at partnerships - but want to be strong position before the close any of those for good reasons at this advanced stage.

Tomorrow we go up here - did not get to buy much today - was fun to watch the BS before 1 hour before close - as was on NASDAQ market most of the day.

Looks like we have bunch of kids here :) kids who sold or want in and trolling on the dips

I was glad it dipped here into close on low vol from .70s in like 15mins - extra here after massive 60% drop yesterday from approx. 175p

If you sold the dips - well done - you will do very well here. Glad you are our or short - congrats ]

If you bought yesterday and today, and accumulating - no congrats to you - you were greedy and did not do the charity work for the trolls or wanna be buyers. They need your charity here under 100p at least.

Distress sellers are our and any bear in low and max margin calls Friday for them.

This is toast, a good toast for later - INHO

Lets see end of fay sellers

have order below its not filling!

sell if you scared here. Short here if you are confident - lets go!

I don't. If they were real investors they would not have sold - you see. Good to have old wood out low last 2 days.

but we have trolls= bears so good to have them down here all day long

more tomorrow

have a great evening.

AimNews

no is pumping fella

more buys than sells - you mis the point

price don't matter now its all low since yesterday dip

having dry powder to buy off bears/ weakhand does

easy buy and hold here

no point selling now either....hmmm..... hmmm

Hence the big dip

Always overdone

Many paid 175-275p - the heck don't buy here.

This will fly soon

Faron is now at a really important stage with bexmarilimab. The science is proven, and the focus has shifted to moving the drug forward as quickly and efficiently as possible.

The board has taken a close look at the development plan and funding needs, and the proposed raise has a very clear purpose. It’s aimed at fully funding the Phase II part of a Phase II/III registrational trial in front-line high-risk MDS, a trial design that has already been agreed with the FDA in the second half of 2025.

At the same time, the funding allows Faron to continue combination studies in solid tumors, keeping the upside from other cancer areas alive.

Put simply, this isn’t about keeping the lights on — it’s about backing a drug at the point where real value gets created. Funding now helps push bexmarilimab toward approval and sets the company up for the next major re-rating as milestones are delivered.

You don't have to buy / you can sell low and move on. Just do your dd

here is i see a massive opp now here after seeing new troll posters out the blue at 120p yesterday

its not a long hold here and extra dips are supper nice to have for long buyers and holders

most day traders lose BTW

Have a nice day, more dd later.

Clintek - so you sold or got trolled out your so easy fella

I said yesterday keep dry powder handy and buy in stages.

Any now you sold you can move on then. This is the markets not you mummy/ daddy home

Looks like everyone sold out from 175p in panic in 2 days.

oh well, trolls will be happy then

mms must be lived here

Hence why i said keep dry porder handy

no can predict price

but sellers out low is better long haul

if anyone sold they sold at loss

and trolls = bears taking a punt here - punt is punt

Value is much higher here - I posted some research numbers / market last night

not a single troll provide that info here BWT - Why would they ....

Manipulation at its finest

easy to see

good to see

down from 175p to 55p - not bad by means